CHAPTER XV

GOUT AS AN INFECTION (_continued_)

ANALYSIS OF THE ACUTE PAROXYSM

If we reflect on the general features and local characters of an

initial outbreak of gout they are precisely such as would, did they

occur anywhere but at the classic site, _the big toe_, suggest an

_infection_. The abrupt onset, the local signs, the crisis, and no less

the subsequent swift restoration to health, how strikingly reminiscent

of an _exanthematous_ fever! Moreover, does not this outward clinical

resemblance seem to predicate an inward pathological similarity? And

now to scrutinise more narrowly the component elements that make up the

content of a paroxysm of gout.

Its fulminant _onset_, with shivering, if not a definite rigor, in a

person in sound and sometimes exuberant health, irresistibly reminds one

of the sudden onfall of an infective disorder. Doubtless, as Duckworth

says, “the conditions leading up to the attack have been some time

previously in operation.” But, as he rightly contends, “some determining

factor must now be invoked to explain how, as it were, the train is

fired.” Quite so, and what more likely to call into the open these latent

morbid potentialities than an _infection_?

_The constitutional disturbance_ is often profound, certainly out of all

proportion to the severity and extent of the local phenomena. Especially

prominent are the _nervous_ concomitants—the excruciating pain, the

irascibility, etc. Viewing these in light of the paroxysmal nature and

periodicity of gout, Duckworth postulated a kinship between the disorder

and the _paroxysmal neuroses_. But, given an infective element, what

more plausible than to attribute the nervous phenomena of gout to the

simultaneous action of its _toxins_ on the higher centres?

The _temperature_ curve, again, is obviously compatible with this

conception. It begins abruptly, its course punctuated by daily

remissions. No specific peculiarities apparently differentiate it from

other arthritides of established or assumed infective origin, but its

relatively low grade pyrexia recalls that typical of _gonococcal_

arthritis. Its most striking feature, however, is the disproportion

between the level of the pyrexia and the intensity of the general

and local phenomena. Moreover, the temperature is not only low, but

relatively ephemeral in duration, while the inflammatory reaction in its

violence emulates that of the most sthenic forms of arthritis.

Albeit both the febrile disturbance and the local reaction display

infinite grades of severity. Thus, _acute gouty polyarthritis_ may be

_afebrile_ and the _asthenic_ varieties of the affection marked by little

inflammatory reaction. All these vagaries, however, are quite compatible

with infection—the reflex, as it were, of varying degrees of _toxæmia_.

Says Duckworth, “The pyrexia proper to acute gout is paroxysmal

with remission, and the pain of gout is likewise paroxysmal. One is

reminded of the influence of marsh poison upon the nervous centres.

This paroxysmal no less than periodic element in gout stamps a

nervous character upon the malady and binds it in alliance with other

well-recognised neuroses.”

How interesting these reflections by this distinguished physician in

light of latter-day revelations! For, in so far as these features in gout

are reminiscent of _malaria_, they disclose an affinity, not for a malady

of nervous, but one of established _infective_, origin.

Simultaneously with the onset of _pyrexia_ the pulse quickens. The blood

shows that increase in fibrin characteristic of inflammation, a fact

noted by Gulland, Cabot, Buchanan and others. But more significant is the

presence of _leucocytosis_. It may be of high grade. In a case of acute

gouty _polyarthritis_ recently under my care the leucocyte count reached

27,000. Even in a _subacute_ example of the classic _monarticular_

type the leucocyte count attained 25,920. It was of _leucoid_ type and

attended by moderate anæmia due to deficiency of red corpuscles.

Nor is leucocytosis restricted to the periods of exacerbation, but it

may be met with in the _inter-paroxysmal_ stages. In my experience, even

in cases of definitely _chronic_ type it may reach 14,000. The higher

grades of leucocytosis are obviously very suggestive of an _infection_,

and that lesser degrees should be encountered in examples of definitely

chronic type seems to point to gout being of the nature of a _chronic_ or

_serial_ infection.

I would here add also that the converse of leucocytosis, viz.,

_leucopenia_, is sometimes met with in chronic cases. Dr. Munro and I

have met with two instances of such in chronic gout in the intervals

between paroxysms. This decrease in the number of leucocytes (leucopenia)

is, of course, deeply interesting and, needless to say, quite compatible

with infections, _e.g._, enteric, malaria, tuberculosis. In fact, it

suggests that gout may be the outcome of divers infections, and not due

to any specific organism.

_Enlargement of the lymphatic glands_ was, by older authors, believed not

to occur in gout. But obviously the lack of macroscopic evidence does not

exclude the possibility of microscopic changes in these structures. The

likelihood of such, moreover, is enhanced by the occasional occurrence

of _lymphangitis_ in connection with the inflammatory articular lesions.

Buzzard, indeed, long since claimed that there was “clinical evidence of

subacute gouty inflammation of lymph spaces in certain regions due to

uratic deposit and influence.”

As a matter of fact, enlargement of the lymphatic glands does occur.

Thus, my colleague James Lindsay cites an instance thereof. The subject,

a painter, fifty-three years of age, had gout of some three years’

standing. During an acute paroxysm thereof “there was a mass of glands

in the right groin, synchronous with an acute inflammation affecting the

right knee and periarticular tissues. On the subsidence of the gouty

inflammation the glands became smaller, but never entirely disappeared

during the four weeks he was subsequently under observation.”

_Splenic enlargement_, states Duckworth, has been met with in many cases

of gout, and occasionally infarcts. But such splenic enlargement is, he

thinks, _not specifically_ related to gout, but is due to associated

conditions. Personally, I have not as yet met with splenic enlargement in

gout.

This aside, is it not palpably significant of infection that Paget,

Garrod, and others, repeatedly noted the incidence of acute _phlebitis_

in a limb the seat of acute articular gout? Did we observe such a

complication in any arthritis other than gouty, should we not inevitably

regard it as indicative of the spread of an _infection_ from the joint to

the related veins?

Reverting to the _local articular phenomena_, they are not only

compatible with, but emphatically suggestive of, an _infective source_.

The typical signs of inflammatory reaction are swiftly installed in

acute classical gout, and this with an intensity unrivalled save by the

most sthenic types of acute arthritis. Witness how insistent were our

forefathers, _e.g._, Scudamore, on the differentiation of acute gout,

not so much from acute rheumatism as from _erysipelas_ or _phlegmon_.

Garrod, indeed, held that “if a medical man, by chance entirely ignorant

of the nature of gout, were to see a toe affected by this disease in its

full intensity, swollen, hot, red, and tender, he would probably think

that the affection must of necessity terminate in suppuration, yet I

believe this never happens as the result of simple gouty inflammation.”

This leads us to note a salient feature of gouty inflammation, viz.,

it never results in _pus formation_. Now, allowing for the increased

powers of discrimination that happily to-day are ours, is it not, I ask,

significant that the disorders deemed most likely of confusion with acute

gout belong to the frankly _infective_ category?

That Garrod’s _caveat_ was not uncalled for I feel sure, having myself

known an acute gouty arthritis incised in the hope of evacuating pus.

Sometimes the error in judgment is reversed and _pyæmic_ or _septic_

conditions in or near the great toe joint confounded with gout. Thus, Sir

James Paget tells of an instance in which a pyæmic abscess forming near

the great toe and consequent upon ligaturing of piles was thus confused.

I recall, too, another example in which the supposed gouty arthritis of

a great toe was of pyæmic nature, the outcome of a suppurating otitis

media. Garrod, it may be recollected, ranked _pyæmia_ as one of the

disorders to which gouty subjects were especially liable.

Gouty inflammation resembles most other forms of the same morbid change,

but some, however, contend that the association of _œdema_ therewith is

pathognomonic. Indeed, by some of the older authors this concomitant

feature of gouty inflammation ranked as a criterion differentiating it

from “true rheumatic inflammation.” Œdema, of course, is not distinctive

of gouty as opposed to other forms of inflammation. But its occurrence

therein is, we would submit, but another token of its affinity with the

_infective_ arthritides. We need but recall the constancy with which

local œdema is met with in, _e.g._, _gonococcal_ arthritis. More typical

of gout, however, is the _desquamation of the cuticule_ that follows

the subsidence of the acute arthritis. Here we are reminded of the

similar peeling of the skin that occurs in another _infective_ disorder

associated with arthritis, _i.e._, _scarlatina_.

Acute gout is _definitely paroxysmal_. The attack, at any rate when

primary, is relatively ephemeral, lasts but a few days, and after it

has passed, as Cullen says, “leaves the person in very perfect health,

enjoying greater ease and alacrity in the functions of both body and mind

than that for a long time before experienced.”

In short, acute gout would appear to be a self-delimited disease, its

fleeting duration predicating that if an organism be responsible, the

same is short-lived. Even in _chronic_ gout, though it never quite loses

its grip of those it has made its prey, yet nevertheless there are

intervals of respite between the attacks, however long the latter may be.

In other words, the disease never loses its paroxysmal character, which

to my mind is very suggestive of a serial infection.

The _periodicity_ of gout was, as we have seen, well known to the

ancients. Its recurrence in early spring and late autumn has even been

celebrated in verse:—

“On whose sacred internodial Altars I

Each Spring and Fall at least will sacrifice

Morbifick, painful loads of Matter tartarous,

With recrements of nervous juice impregnate.”

“The Honour of the Gout,” by _Philander Misaurus_.

Scudamore referred its prevalence at these particular seasons to their

attendant vicissitudes of heat and cold (the strongest of all the

exciting causes of gout). Trousseau states that “gout with successive

paroxysms shows itself early or late in the year, at the beginning of

spring or late autumn, the wherefore I know not.”

This tendency on the part of acute gout to seasonal rhythm is ultimately

lost. For, once the disorder is established, no period of the year

confers absolute immunity. Whatever be the explanation of the vernal and

autumnal incidence of gout in its early stages, this peculiarity is at

any rate not incompatible with its _infective_ origin. In this connection

it may be recalled that it was once described as “a tertian fever

terminating in fourteen days.”

Again, further evidence may be obtained from the action of colchicum,

our sheet-anchor in the treatment of gout. Thus, Dixon and Malden have

shown that _colchicine_ has no action on the metabolism of _purins_ or on

the _kidney_. On the other hand, it causes a primary diminution followed

by a _marked increase_ in the number of _leucocytes_, which suggests

the possibility that it exerts its beneficial effects by combating

_infection_.

Lastly, turning our attention to the anatomical changes as disclosed

after death during an acute articular paroxysm, these present appearances

quite compatible with their infective origin. Dr. Munro, in one of my

examples of _acute gouty polyarthritis_, aspirated the knee joint. The

results of _cytological_ examination were precisely such as are deemed

characteristic of arthritides of infective source.

The results of our analysis of the component elements of an acute

paroxysm of gout are, for the following reasons, strongly indicative of

the intrusion of an _infective_ element:—

(1) The onset, temperature curve, the character of the local

phenomena, and course of the disorder.

(2) The presence of _leucocytosis_ with secondary anæmia, and

exceptionally of _leucopenia_.

(3) Enlargement of the lymphatic glands, and possibly of the

spleen.

(4) Occasional complication of the acute articular disorder by

_lymphangitis_ and _phlebitis_.

(5) The paroxysmal nature and periodicity of the disorder.

(6) The compatibility of the morbid anatomical changes and the

cytological content of aspirated joint fluid with their genesis

by infection.

THE EVOLUTION AND LIFE HISTORY OF GOUT

If the onset, phenomena, and course of acute gout are reminiscent of

infection, so, also, does a review of the life history of the disease, as

a whole, carry with it the same inference.

For the course of gout, like other arthritides of chronic type, is

not one of steady, uninterrupted progress, but one marked rather by

_periodic_ or _intermittent_ advances, as if seemingly due to a series

of successive _infections_ or _sub-infections_. One is reminded of

_gonococcal_ arthritis in its more severe forms, the acute exacerbations

which chequer its course being generally referred to intermittent

absorption of fresh doses of the toxin from some smouldering infection in

the prostatic urethra.

Now, if the general course or evolution of _gouty_ arthritis is notably

similar to that of the specific infective arthritides, so, also, do the

clinical features approximate. Thus its _onset_, more often than not, is

_abrupt_ and attended by pyrexia of _irregular_ or _septic_ type, with an

occasional _leucocytosis_.

Again, that not all cases of gout are of _acute fulminant_ type may

be admitted. We know that it may assume the guise of a fleeting

_arthralgia_ or “flying gout,” a transient _synovitis_, as well as an

acute _arthritis_ of _mono-_, _oligo-_, or _poly-articular_ extent.

This same _polymorphism_ in respect of the joint lesions in gout is a

replica of that met with in the _specific infective arthritides_. The

milder varieties betokened by arthralgia or synovitis tend commonly to

disappear, as it were, spontaneously in precisely the same manner as the

arthralgias or synovites that follow the exanthemata, and we presume

that, comparably with these latter, the source of infection dries up and

_restitutio ad integrum_ of more or less completeness follows.

But with repeated attacks, as in the specific infective arthritides,

progressive infiltration and thickening of ligaments, capsule, and

related tendinous and aponeurotic structures ensue. As far as these

anatomical changes are concerned, gouty arthritis and the specific

arthritides are at one, but with this outstanding difference, the

associated _uratic deposition_. Save in respect of this last, the analogy

is complete, and herein resides the specificity of gouty arthritis.

Chalmers Watson, from his observations of “gouty deposits” in human

subjects in their relation to _tendons_, _cartilage_, and _bone_, came to

the conclusion that the _tout ensemble_ of the pathological lesions was

very reminiscent of that typical of the more chronic types of _infective_

disorders. Thus necrotic areas in gouty tendons stood in such clear

relationship to the vascular supply as to suggest some infection _viâ_

the blood-stream. Again, areas of erosion in the cartilage were found to

be due, not to uric acid, but to the disintegrating action of small round

cells of the nature of granulation tissue.

As to uratic deposits located in the _bones_, it was noted that their

vicinity was characterised by marked vascularity, the existence of

giant cells, and an accumulation of the small round cells so commonly

correlated with the action of bacterial toxins.

In reviewing the foregoing clinical and pathological data and, alike, the

inferences as to their significance, it cannot, we think, be gainsaid

that, collectively, they are more readily explicable as being due to an

infection than to any other morbid source.

ANALOGIES BETWEEN GOUT AND THE SPECIFIC INFECTIVE ARTHRITIDES

A striking parallel can be drawn between the varied manifestations of

gout and those met with in _specific infections_. But, to begin with, we

must recall that our attitude towards infective disorders, _e.g._, acute

rheumatism, gonorrhœa, etc., is altered in that we regard them now, not

as local, but _general_, systemic infections.

Thus, following the revelations of bacteriologists, we now, for

example, recognise that in _gonococcal_ infection not only may there be

_articular_ involvement, but that _muscular_ and _nervous_ lesions may be

associated therewith. This same, also, in _acute articular rheumatism_.

True, its causal organism is still _sub judice_, but data accumulate as

to the frequency with which the _muscles_ are involved, and, to a less

extent, the sheaths of _nerves_.

Take _dysentery_, again; it, too, as Sydenham pointed out, may be

complicated, not only by _arthritis_, but by _myalgias_, while more

recent experience emphasises the frequency with which _neuralgias_

are associated therewith. In _syphilis_, also, the association of

_articular_, _muscular_, and _nerve_ lesions is well attested; and by

French physicians it is insisted that, in _tubercle_, myalgias and

neuralgias, as well as joint disorders, are infinitely more common than

is generally realised.

To sum up, this _triad_ of _arthritic_, _muscular_, and _nerve_ lesions,

either serially or simultaneously, is the most common complication of

_specific infections_. Now, is not this same congeries of articular,

muscular, and nerve disorders precisely the clinical content of _gout_?

Thus its _articular manifestations_ constitute the most striking feature

of the disease. As to the _muscular_ troubles, there is a consensus of

opinion as to their relative frequency. Inflammatory foci with associated

uratic deposit have been found in muscles and tendons. We may here recall

that the purin bases of the body exist, not only in the bound form

(nucleic acid), but also _free_, especially in _muscular_ tissue, also

that from such free purin bases _uric acid_ can be as readily formed as

from those liberated by disruption of nucleic acid.

Clinically, one meets with all forms of fibrositis in actual association

with acute articular gout. Such may affect either the neck, shoulder,

loin, or sciatic nerve. In their work on “Fibrositis,” Bassett Jones

and Llewellyn have shown that the disorder develops with significant

frequency in the victims of gout. This but confirms the conviction held

by Gowers, Garrod, Hilton Fagge, and others, viz., that the muscular and

nervous types of fibrositis are frequently and obviously related to gout.

How noteworthy the well-established proclivity of gout to involve

bursæ, tendon sheaths, and fasciæ, especially the plantar! Is not this

exactly paralleled in certain _infections_? Note the predilection of

post-scarlatinal rheumatism for bursæ and tendon sheaths; that of the

gonococcus for these structures as well as fasciæ, not to mention the

frequency with which bursal enlargements are traceable to syphilitic,

tuberculous, and other infections.

We see, therefore, that in virtue of its tendency, not only to

_arthritic_, but also to _muscular_ and _nerve_ disorders, gout falls

into line with the _specific infections_. Its predilection for bursal and

fascial structures is but another evidence of affinity with this group of

disorders. In view of these similitudes, one may well ask, Are not these

_gouty_ manifestations, all of them, susceptible of a like explanation,

viz., that they are the outcome of an _infection_?

For, in reviewing the foregoing analogies, it cannot, we think, be denied

that in the aggregate they are emphatically suggestive of an infective

origin.

CORRELATION OF THE METABOLIC PHENOMENA OF GOUT WITH THE POSTULATED

INFECTIVE ELEMENT

In essaying this difficult task, we must recall to the mind of the reader

our findings or deductions from the data disclosed in preceding chapters.

The outstanding conclusions that we felt justified in formulating were

that:—

(_a_) Uric acid is not the cause but the _consequence_ of gout.

(_b_) _Inflammatory reaction_ is, we believe, an invariable

precursor in all gouty processes.

In other words, we suggest that, although abnormalities of metabolism

form an integral part of gout, they are of themselves inadequate to

achieve its efflorescence. Thus, when we came to consider the elemental

manifestations of gout, _i.e._, uratic deposits or _tophi_, we saw that

neither the purely physical nor the purely chemical theory of their

origin would suffice, nor, for that matter, could any solution of this

complex problem be gleaned from even a blend of the twain. In short, such

hypotheses are too _mechanical_. The intrusion of some other factor,

“some vital something biological,” seems essential for the elucidation

of _uratosis_, _i.e._, uratic deposition. For this, _not uricæmia_, is

the specific characteristic phenomenon of gout. If we cannot explain

uratosis on physical or chemical grounds, then how much less, in view of

the _non-toxicity_ of _uric acid_, can we, on this basis, account for the

_inflammatory_ phenomena of the disorder?

_Inflammatory reaction_ is, we hold, an invariable _antecedent_ in all

gouty processes, whether of _articular_ or _ab-articular_ site. Granted

that inflammatory reaction is a necessary prelude, the specificity of

gout is attested by the fact that this same is followed by the deposition

of urates. But while the sequential uratic deposition invests all forms

of “gouty” inflammation with a specific character, unshared by any other

disease, it follows that the cause of the said inflammation must, if

possible, be ascertained.

For Walker Hall “the contention that gout lowers the general tissue

resistance, and so opens the way to bacterial infections, is so

obvious that it need hardly be formulated.” In light of this, we need

have the less diffidence in hazarding our opinion that the morbific

agent responsible for “gouty” inflammation is an _infection_ or

_sub-infection_. Now, in all forms of arthritis other than gouty, the

intrusion of a germ is held to be self-explanatory and final; in short,

all the local morbid changes and constitutional disturbances are held

satisfactorily accounted for by the organism or its toxins.

The problem of gout, however, is not so simple. Its arthritis is peculiar

in that it is always accompanied or followed by _uratic deposition_,

which, be it noted, is not an ordinary sequel of inflammation. It is, in

short, the outcome of inflammation supervening in an individual of _gouty

diathesis_. What do we know of this latter?

The researches of the bio-chemists reveal that _uric acid_ is the

end-product of nuclein metabolism—the summation of a long chain of

enzymatic reactions. Some indeed have thought to find an adequate

explanation of gout in _enzymatic abnormalities_. Thus, Adami and McCrae

suggest that gout is the outcome of _insufficient oxidation_, whereby the

precursors of uric acid and similar bodies are not fully oxidised, and,

by their accumulation and toxicity, set up morbid changes, and the uric

acid formed is, in its turn, imperfectly oxidised and accumulates. This

diminished oxidation is due to a constitutional deficiency of _oxydases_,

inherited or acquired.

This opens up the old problem as to whether uric acid is an intermediary

or a terminal product of metabolism. But, from evidence cited in

preceding chapters, it appears probable, if not certain, that uric acid

is an end-product. Moreover, as Gideon Wells observes, “the failure

of recent studies on the enzymatic transformation of purins to locate

anywhere in the human body an enzyme-destroying uric acid makes hazardous

the attempt to explain gouty metabolism as a result of enzymatic

abnormalities.”

Indeed, in view of this, as hitherto ascertained, _absence of uricolytic

enzymes_, there can, as Wells says, “be little doubt that the fundamental

reason for the existence of uric acid gout in man lies in the inability

of the human organism to destroy uric acid. Consequently, inasmuch as

man, unlike other mammals, cannot destroy uric acid rapidly by oxidation,

he is always a potential victim of uric acid retention and deposition.”

Now we have, we hope, shown that there is no evidence that the _uric acid

retention_ in gout is due to functional inability on the part of the

_kidney_ to excrete uric acid. This being so, we have, as Von Noorden

rightly says, no right to do violence to the facts by assuming that, in

a case lacking any other evidence of _nephritis_, a condition of “latent

nephritis” is the cause of the uric acid retention and deposition.

Similarly, there is at present no evidence forthcoming that the retention

of uric acid is due to _abnormal purin combinations_ in the _blood_. Nay,

according to Wells, on the best evidence obtainable, uric acid exists in

a _free_ state in the blood, and not combined, as has been urged by many

workers in this sphere.

But if the cause of _uric acid retention_ lies neither in the _kidneys_

nor in the _blood_, there must exist something abnormal in the gouty

individual which renders impossible what may be termed a _compensatory

uric acid excretion_. Now, as disclosed in the previous chapter,

experimental research, in diseases other than gout, has shown that the

_bodily tissues have an appreciable capacity for retention of uric

acid_ (Fine). This, moreover, gains probability from the fact that

Wiechowski, in his prolonged studies as to the possibility of uric acid

decomposition in the human body, was never able to detect any evidence

of _uricolysis_. Furthermore, on the clinical side, the fact that

_intravenous injection of uric acid_ does not produce a corresponding

degree of _uricæmia_ seems, as Bass and Herzberg suggest, to indicate

that in gout the _retention capacity of the tissues for uric acid is

augmented_. Lastly, in the precipitation and anchoring of urates in the

tissues in gout, we have objective proof, _i.e._, tophi, that the uric

acid is actually held in the tissues.

Does not this seem to indicate that there are _peculiarities of tissue in

the gouty_? What, then, the subtle change that determines the _retention

and deposition_ of urates in the tissues in gout?

May we not, with Walker Hall, hazard the reflection that there may be

differences between the _nucleotides_ of normal and gouty tissues? For,

doubtless, if there be peculiarities of tissue in the gouty, these will

be reflected in abnormalities of _tissue function and metamorphosis_.

Gowlland Hopkins, discussing the metabolism of purins, holds that in gout

there is some disturbance or defect in the _fermentative functions of the

tissues_. Of a verity the range of _intranuclear_ activities offers scope

enough when we recollect that the cells of all tissues contain not only

_nucleinase_, but also _nucleotidase_ and _nucleosidase_. Even so, the

resultant nucleins, the nucleotides, and nucleosides, have still further

changes of deaminisation and oxidation to undergo, these carried out in

the liver and elsewhere!

We may talk of defects in the enzymatic functions of the tissues, but,

viewing gout clinically, and more particularly the hypersensitiveness

of its victims to the most varied stimuli, dietetic and other, one

inclines rather to predicate in their instance an inherent _instability_

of _nuclein metabolism_. For in the gouty, as Walker Hall observes,

“a slight injury or indiscretion of diet, an overloaded intestine,

or increased toxicity of the intestinal flora, may be followed by a

disturbance of the general nuclein metabolism, and a local reaction in

certain tissues.”

With this pronouncement all clinicians will be in accord, and herein,

too, we may, I think, discern how the latent tissue idiosyncrasies of the

gouty are evoked, _i.e._, by _infection_; in other words, that, under the

influence of these morbific agents, the innate morbid potentialities of

the gouty become overt and manifest.

The exact _modus operandi_ whereby the assumed organisms or their

toxins determine the _efflorescence_ of gout is uncertain. We know

that, following the intake even of _non-purin-containing foodstuffs_,

an _increase in uric acid excretion_ ensues, and that the same is the

outcome of the stimulation of _general_ nuclein metabolism. Is it not

conceivable that the responsible toxin acts in like fashion, and haply by

disturbing the orderly sequence of those exquisitely delicate enzymatic

reactions which culminate in the formation of uric acid, and with which

potentialities every living cell in the organism is dowered? Further than

this we, pending future researches by the bio-chemists, may not go, for

“the positive material is much too insufficient, and much too ambiguous.”

In conclusion, I would postulate that in _gouty_ subjects:—

(1) There is an inherent abnormality or instability of

_nuclein_ metabolism, and conjoined therewith an enhanced

tissue affinity or augmented retention capacity for uric acid.

(2) These latent tissue peculiarities, through the agency of

_infections_ or sub-infections, become manifest as gout.

(3) The said organism or organisms excite inflammatory reaction

with sequential uratic deposition, either of articular or

ab-articular site.

(4) The predilection of such uratic deposition for certain

particular tissues is determined by their greater content of

sodium ions as compared with the blood.

(5) The local and general phenomena of gout, its paroxysmal

nature and tendency to periodicity, are most readily explicable

on the basis of a _chronic infection_ supervening in a subject

the victim of those innate peculiarities of tissue with their

correlated obliquities of function which connote what we term

the “gouty diathesis.”

Gout, with a section on ocular disease in the gouty · 第 15 / 33 章